Topic outline
Minimum statistical knowledge required for clinical trials on cancer - Part 1 of 2
Some key points for interpreting the results of phase III randomized controlled trials are introduced in this lecture. Particularly, this part outlines survival curve and randomization.
0:18:37
Minimum statistical knowledge required for clinical trials on cancer - Part 2 of 2
Some key points for interpreting the results of phase III randomized controlled trials are introduced in this lecture. Particularly, this part outlines verification and evaluation of results, and ITT analysis set.
0:25:21
Designs for clinical trials on cancer - Part 1 of 2
Development flow and clinical trial designs of anticancer drugs are introduced in this lecture. Particularly, this part outlines development flow and phase I clinical trial designs.
0:31:42
Designs for clinical trials on cancer - Part 2 of 2
Development flow and clinical trial designs of anticancer drugs are introduced in this lecture. Particularly, this part outlines phase II and III clinical trial designs.
0:24:56
Response evaluation and adverse events - Part 1 of 2
Methods for response evaluation and adverse event reporting used in clinical trials on cancer are introduced in this lecture. Particularly, this part outlines response evaluation.
0:27:58
Response evaluation and adverse events - Part 2 of 2
Methods for response evaluation and adverse event reporting used in clinical trials on cancer are introduced in this lecture. Particularly, this part outlines adverse event reporting.
0:21:48